J. Enzym. Inhib. Med. Chem. 2020, 35, 398-403.

Biological exploration of a novel 1,2,4-triazole-indole hybrid molecule as antifungal agent.

Bioorg. Med. Chem. Lett. 2014, 24, 3748-3752.

Discovery of (7-aryl-1,5-naphthyridin-2-yl)ureas as dual inhibitors of ERK2 and Aurora B kinases with antiproliferative activity against cancer cells.

ChemMedChem 2014, 9, 217-232.

Discovery of 7-Aryl-Substituted (1,5-Naphthyridin-4-yl)ureas as Aurora Kinase Inhibitors. 

ChemMedChem, 2011, 6, 816-825.

Design, synthesis and in vitro antifungal activity of 1-[(4-substituted benzyl)methylamino]-2-(2,4-difluorophenyl)-3-(1H-1,2,4-triazol-1-yl)propan-2-ols.

Bioorg. Med. Chem. Lett., 2009, 19(20), 5833-5836.

Design of new antifungal agents: synthesis and evaluation of 1-[(1H-indol-5-ylmethyl)amino]-2-phenyl-3-(1H-1,2,4-triazol-1-yl)propan-2-ols.

J. Enz. Inh. Med. Chem., 2009, 24(5), 1067-1075.

Design, synthesis and evaluation of 3-(imidazol-1-ylmethyl)indoles as antileishmanial agents. Part II.

Bioorg. Med. Chem. Lett., 2009, 19(2), 301-304

Synthesis and structure-activity relationships of 2-phenyl-1-[(pyridinyl- and piperidinylmethyl)amino]-3-(1H-1,2,4-triazol-1-yl)propan-2-ols as antifungal agents.

Bioorg. Med. Chem. Lett. 2008, 18(6), 1820-1824.

Design, synthesis, and evaluation of 1-(N-benzylamino)-2-phenyl-3-(1H-1,2,4-triazol-1-yl)propan-2-ols as antifungal agents.

Bioorg. Med. Chem. Lett. 2008, 18(16), 4713-4715.

Synthesis of 6- or 4-functionalized indoles via a reductive cyclization approach and evaluation as aromatase inhibitors.

J. Enz. Inh. Med. Chem. 2007, 22(5), 667-676.

Synthesis and biological evaluation of 3-(azolylmethyl)-1H-indoles and 3-(alpha-azolylbenzyl)-1H-indoles as selective aromatase inhibitors. 

Bioorg. Med. Chem. Lett. 2007,17(13), 3686-3689.

Synthesis and antifungal activities of new fluconazole analogues with azaheterocycle moiety.

J. Enz. Inh. Med. Chem. 2006, 21, 277-283.

3-(a-Azolylbenzyl)indoles: in vitro and in vivo anti-Leishmania activity and mechanism of action.

Bioorg. Med. Chem. Lett. 2006, 16, 1134-1137.

Synthesis and biologicol evaluation of 5-[(aryl)(1H-imidazol-1-yl)methyl]-1H-indoles: Potent and selective aromatase inhibitors.

Tetrahedron Lett. 2006, 47, 6479-6483.

Efficient microwave-assisted synthesis of 2-phenyl-1-(1H-indol-1-yl)-3-(1H-1,2,4-triazol-1-yl)propan-2-ol derivatives with potential antifungal activity.

SAR and QSAR in Environ. Res. 2006, 17, 299-309.

3D-QSAR COMSIA study on 3-azolylmethylindoles as anti-leishmanial agents.

J. Enz. Inh. Med. Chem. 2005, 20, 581-585.

Three-Dimensional Model of Cytochrome P450 Human Aromatase.

Mycology 2004, 11 (supplement 1), 43.

Antifungal activity of new azolylindole derivatives against Candida and Aspergillus. Proceedings of the 10th Congress of the European Confederation of Medical

J. Enz. Inh. Med. Chem. 2004, 19, 451-457.

Synthesis and antileishmanial activity of 3-imidazolylalkylindoles. Part I.

J. Enz. Inh. Med. Chem. 2004, 19, 549-557.

2- and 3-[(Aryl)(azolyl)methyl]indoles as potential non-steroidal aromatase inhibitors.

Eur. J. Med. Chem. 2003, 38, 75-87.

Synthesis and antifungal activity of new 1-halogenobenzyl-3-imidazolylmethylindole derivatives.

Brevet US 2004067998 A1 publié le 8 avril 2004.

Brevet CN 1473160A publié le 4 février 2004.

Brevet EP 1322638 publié le 2 juillet 2003.

Brevet CA 2 423 151 A1 publié le 21 mars 2003.

Brevet PCT WO 02/24685 A1 déposé le 21 septembre 2001, publié le 28 mars 2002.

Brevet FR 2 814 073 - A1 déposé le 21 septembre 2000, publié le 22 mars 2002.